Largest Diagnostics & Research Companies by Market Cap
Largest Diagnostics & Research companies by market cap. The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $1.09 Trillion. Thermo Fisher Scientific Inc leads the sector with a market cap of $224.59 Billion. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Diagnostics & Research Stocks by Market Capitalization (October 2026)
Top Diagnostics & Research stocks by market capitalization as of October 2026, covering 167 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Thermo Fisher Scientific Inc
NYSE:TMO |
$224.59 Billion | $224.59 Billion | USA | $709.18 | +0.71% | +2.18% | 55.74 Million |
| 2 |
Danaher Corporation
NYSE:DHR |
$167.39 Billion | $167.39 Billion | USA | $236.98 | +1.24% | +1.33% | 109.22 Million |
| 3 |
Natera Inc
NASDAQ:NTRA |
$56.33 Billion | $56.33 Billion | USA | $436.00 | +2.73% | +5.47% | 38.19 Million |
| 4 |
WuXi AppTec Co Ltd
SHG:603259 |
$51.71 Billion | CN¥353.41 Billion | China | CN¥142.89 | +0.34% | -3.03% | 1.01 Billion |
| 5 |
Agilent Technologies Inc
NYSE:A |
$43.76 Billion | $43.76 Billion | USA | $181.15 | -0.18% | +1.91% | 50.96 Million |
| 6 |
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
$41.04 Billion | €35.10 Billion | Germany | €54.50 | +0.00% | -3.54% | 230.00 |
| 7 |
IDEXX Laboratories Inc
NASDAQ:IDXX |
$40.58 Billion | $40.58 Billion | USA | $575.98 | +2.32% | +4.07% | 12.19 Million |
| 8 |
IQVIA Holdings Inc
NYSE:IQV |
$39.29 Billion | $39.29 Billion | USA | $275.06 | -1.43% | -0.57% | 32.74 Million |
| 9 |
Lonza Group AG
SW:LONN |
$37.10 Billion | CHF29.35 Billion | Switzerland | CHF640.80 | +1.75% | +2.76% | 3.18 Million |
| 10 |
Waters Corporation
NYSE:WAT |
$34.91 Billion | $34.91 Billion | USA | $480.07 | +0.67% | +4.94% | 21.33 Million |
| 11 |
Labcorp Holdings Inc.
MX:LH |
$29.10 Billion | MX$505.61 Billion | Mexico | MX$6099.00 | +29.62% | +24.22% | 1.28K |
| 12 |
Mettler-Toledo International Inc
NYSE:MTD |
$28.64 Billion | $28.64 Billion | USA | $1718.61 | +1.19% | +2.42% | 4.57 Million |
| 13 |
Quest Diagnostics Incorporated
NYSE:DGX |
$26.31 Billion | $26.31 Billion | USA | $252.92 | +2.97% | +5.86% | 25.63 Million |
| 14 |
Laboratory Corporation of America Holdings
NYSE:LH |
$21.71 Billion | $21.71 Billion | USA | $368.16 | +2.20% | +13.72% | 17.25 Million |
| 15 |
EXACT Sciences Corporation
NASDAQ:EXAS |
$19.80 Billion | $19.80 Billion | USA | $1819.87 | +0.25% | -2.61% | 37.42 Million |
| 16 |
Illumina Inc
NASDAQ:ILMN |
$18.34 Billion | $18.34 Billion | USA | $290.06 | +0.44% | +2.55% | 57.06 Million |
| 17 |
Medpace Holdings Inc
NASDAQ:MEDP |
$16.36 Billion | $16.36 Billion | USA | $677.56 | -2.18% | +2.28% | 7.67 Million |
| 18 |
ICON PLC
NASDAQ:ICLR |
$13.06 Billion | $13.06 Billion | USA | $215.48 | +0.62% | +16.32% | 25.72 Million |
| 19 |
WuXi AppTec Co. Ltd
F:WX8 |
$12.87 Billion | €11.01 Billion | Germany | €21.57 | -0.80% | -2.16% | 2.36K |
| 20 |
Charles River Laboratories
NYSE:CRL |
$12.77 Billion | $12.77 Billion | USA | $376.10 | +0.57% | +9.06% | 25.69 Million |
| 21 |
Guardant Health Inc
NASDAQ:GH |
$12.69 Billion | $12.69 Billion | USA | $185.31 | +1.49% | +11.19% | 42.09 Million |
| 22 |
Revvity Inc.
NYSE:RVTY |
$12.20 Billion | $12.20 Billion | USA | $165.78 | +0.27% | +5.86% | 42.55 Million |
| 23 |
Eurofins Scientific SE
F:ESF0 |
$11.18 Billion | €9.56 Billion | Germany | €59.14 | +0.03% | +0.92% | 2.33K |
| 24 |
Eurofins Scientific SE
PA:ERF |
$10.22 Billion | €8.74 Billion | France | €87.08 | +0.97% | +7.64% | 7.79 Million |
| 25 |
Biomerieux SA
PA:BIM |
$8.48 Billion | €7.25 Billion | France | €90.15 | -0.93% | +4.52% | 4.48 Million |
| 26 |
Qiagen NV
NYSE:QGEN |
$7.79 Billion | $7.79 Billion | USA | $50.34 | +0.02% | +0.68% | 123.58 Million |
| 27 |
ICON Public Limited Company
F:IJF |
$7.52 Billion | €6.43 Billion | Germany | €190.30 | +6.97% | +15.72% | 154.00 |
| 28 |
Sonic Healthcare Ltd
AU:SHL |
$6.67 Billion | AU$9.43 Billion | Australia | AU$19.07 | +1.06% | +1.38% | 34.55 Million |
| 29 |
RadNet Inc
NASDAQ:RDNT |
$5.80 Billion | $5.80 Billion | USA | $73.65 | +0.15% | +7.66% | 12.48 Million |
| 30 |
Sotera Health Co
NASDAQ:SHC |
$5.24 Billion | $5.24 Billion | USA | $18.70 | +0.27% | +5.23% | 47.19 Million |
| 31 |
Hangzhou Tigermed Consulting
SHE:300347 |
$5.20 Billion | CN¥35.56 Billion | China | CN¥48.19 | -0.15% | -5.86% | 242.87 Million |
| 32 |
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN |
$4.66 Billion | $4.66 Billion | USA | $114.84 | +0.74% | +9.72% | 12.17 Million |
| 33 |
Joinn Laboratories(China)Co
SHG:603127 |
$4.22 Billion | CN¥28.86 Billion | China | CN¥45.78 | -2.28% | -5.82% | 981.79 Million |
| 34 |
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
$3.45 Billion | Rs319.21 Billion | India | Rs1911.70 | -0.55% | +4.12% | 6.78 Million |
| 35 |
GRAIL, LLC
NASDAQ:GRAL |
$3.40 Billion | $3.40 Billion | USA | $158.92 | +0.66% | +19.85% | 24.28 Million |
| 36 |
Veracyte Inc
NASDAQ:VCYT |
$3.38 Billion | $3.38 Billion | USA | $52.17 | +3.70% | +12.87% | 29.41 Million |
| 37 |
CareDx Inc
NASDAQ:CDNA |
$2.59 Billion | $2.59 Billion | USA | $71.52 | -0.85% | +1.10% | 32.00 Million |
| 38 |
BGI Genomics Co Ltd
SHE:300676 |
$2.35 Billion | CN¥16.06 Billion | China | CN¥38.39 | -4.22% | -6.14% | 313.82 Million |
| 39 |
Vimian Group AB
ST:VIMIAN |
$2.31 Billion | Skr21.49 Billion | Sweden | Skr40.85 | +1.49% | +7.36% | 6.13 Million |
| 40 |
NeoGenomics Inc
NASDAQ:NEO |
$2.23 Billion | $2.23 Billion | USA | $17.93 | -0.33% | +5.22% | 53.34 Million |
| 41 |
Fleury S.A.
SA:FLRY3 |
$2.21 Billion | R$11.27 Billion | Brazil | R$20.74 | -5.04% | -26.24% | 170.79 Million |
| 42 |
GeneDx Holdings Corp.
NASDAQ:WGS |
$2.12 Billion | $2.12 Billion | USA | $71.02 | +9.79% | +3.02% | 19.50 Million |
| 43 |
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
$1.94 Billion | CN¥13.24 Billion | China | CN¥28.59 | -9.55% | -7.89% | 347.83 Million |
| 44 |
Zhejiang DiAn Diagnostics Co
SHE:300244 |
$1.86 Billion | CN¥12.72 Billion | China | CN¥20.35 | -5.08% | -9.76% | 1.06 Billion |
| 45 |
Syngene International Limited
NSE:SYNGENE |
$1.73 Billion | Rs160.12 Billion | India | Rs398.60 | -2.98% | +5.88% | 52.04 Million |
| 46 |
Personalis Inc
NASDAQ:PSNL |
$1.70 Billion | $1.70 Billion | USA | $15.93 | -0.47% | +0.16% | 52.28 Million |
| 47 |
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
$1.63 Billion | Rs150.81 Billion | India | Rs1464.20 | +1.48% | +8.19% | 2.79 Million |
| 48 |
Freenome, Inc. Common stock
NASDAQ:FRNM |
$1.38 Billion | $1.38 Billion | USA | $12.86 | -4.32% | -8.21% | 15.81 Million |
| 49 |
Opko Health Inc
NASDAQ:OPK |
$1.19 Billion | $1.19 Billion | USA | $1.66 | +2.47% | +3.75% | 116.61 Million |
| 50 |
Amoy Diagnostics Co Ltd
SHE:300685 |
$1.13 Billion | CN¥7.72 Billion | China | CN¥19.79 | -1.64% | +5.55% | 286.89 Million |
| 51 |
Beijing Strong Biotechnologies Inc
SHE:300406 |
$1.07 Billion | CN¥7.33 Billion | China | CN¥12.50 | -2.34% | +4.34% | 160.68 Million |
| 52 |
Castle Biosciences Inc
NASDAQ:CSTL |
$1.00 Billion | $1.00 Billion | USA | $38.51 | +4.99% | +12.05% | 8.50 Million |
| 53 |
Thyrocare Technologies Limited
NSE:THYROCARE |
$887.32 Million | Rs82.05 Billion | India | Rs515.50 | +4.25% | +13.00% | 8.62 Million |
| 54 |
Shanghai Runda Med Tech Co
SHG:603108 |
$859.52 Million | CN¥5.87 Billion | China | CN¥9.73 | -2.99% | -3.18% | 421.74 Million |
| 55 |
Clinica Baviera
MC:CBAV |
$842.36 Million | €720.51 Million | Spain | €53.80 | +0.00% | -0.74% | 53.93K |
| 56 |
Maccura Biotechnology Co Ltd
SHE:300463 |
$796.34 Million | CN¥5.44 Billion | China | CN¥9.00 | -3.23% | -2.28% | 111.45 Million |
| 57 |
Diagnósticos da América S.A
SA:DASA3 |
$723.42 Million | R$3.69 Billion | Brazil | R$2.95 | -6.94% | -45.37% | 49.33 Million |
| 58 |
Cowealth Medical China Co.Ltd.
SHG:603122 |
$641.31 Million | CN¥4.38 Billion | China | CN¥11.01 | -1.96% | -7.40% | 870.20 Million |
| 59 |
HANGZHOU TIGERMED CO. H 1
F:5HZ1 |
$607.45 Million | €519.59 Million | Germany | €4.22 | -2.76% | -7.46% | 0.00 |
| 60 |
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
$585.50 Million | CN¥4.00 Billion | China | CN¥9.99 | -3.94% | -7.24% | 440.73 Million |
| 61 |
Fulgent Genetics Inc
NASDAQ:FLGT |
$562.69 Million | $562.69 Million | USA | $21.68 | +0.74% | +7.70% | 6.54 Million |
| 62 |
Guangdong Hybribio Biotech Co Ltd
SHE:300639 |
$551.54 Million | CN¥3.77 Billion | China | CN¥5.83 | -3.00% | -4.43% | 360.56 Million |
| 63 |
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439 |
$539.32 Million | CN¥3.69 Billion | China | CN¥9.59 | -4.48% | -0.21% | 107.43 Million |
| 64 |
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
$536.90 Million | CN¥3.67 Billion | China | CN¥16.25 | +1.75% | +9.87% | 298.31 Million |
| 65 |
JOONGANG DNM Co.Ltd
KQ:051980 |
$534.94 Million | ₩789.36 Billion | Korea | ₩7120.00 | -15.34% | -16.24% | 19.73 Million |
| 66 |
Berry Genomics Co Ltd
SHE:000710 |
$499.21 Million | CN¥3.41 Billion | China | CN¥9.65 | -2.13% | -10.15% | 1.19 Billion |
| 67 |
Lumibird SA
PA:LBIRD |
$489.86 Million | €419.00 Million | France | €24.90 | +2.89% | +6.64% | 781.37K |
| 68 |
Integral Diagnostics Ltd
AU:IDX |
$468.37 Million | AU$661.94 Million | Australia | AU$1.78 | -14.66% | -16.27% | 24.97 Million |
| 69 |
Voxel S.A.
WAR:VOX |
$455.54 Million | zł1.66 Billion | Poland | zł157.60 | +0.51% | +1.03% | 168.53K |
| 70 |
SMO ClinPlus Co. Ltd.
SHE:301257 |
$378.27 Million | CN¥2.59 Billion | China | CN¥32.72 | -3.37% | -4.13% | 88.11 Million |
| 71 |
Australian Clinical Labs Ltd
AU:ACL |
$360.33 Million | AU$509.26 Million | Australia | AU$3.24 | +2.86% | +10.96% | 10.99 Million |
| 72 |
Chemclin Diagnostics Co. Ltd. A
SHG:688468 |
$344.54 Million | CN¥2.35 Billion | China | CN¥5.87 | -2.65% | -3.14% | 82.55 Million |
| 73 |
Myriad Genetics Inc
NASDAQ:MYGN |
$321.38 Million | $321.38 Million | USA | $6.67 | +0.60% | +19.75% | 68.92 Million |
| 74 |
Metropolis Healthcare Limited
NSE:METROPOLIS |
$310.46 Million | Rs28.71 Billion | India | Rs553.85 | +0.48% | +3.79% | 5.40 Million |
| 75 |
Prenetics Global Ltd
NASDAQ:PRE |
$289.40 Million | $289.40 Million | USA | $18.98 | +2.48% | +13.45% | 4.43 Million |
| 76 |
Integrated Diagnostics Holdings PLC
LSE:IDHC |
$262.18 Million | $262.18 Million | UK | $0.45 | -1.96% | -9.80% | 1.49 Million |
| 77 |
Biodesix Inc
NASDAQ:BDSX |
$260.82 Million | $260.82 Million | USA | $24.72 | +8.14% | +3.30% | 2.39 Million |
| 78 |
Vimta Labs Limited
NSE:VIMTALABS |
$251.20 Million | Rs23.23 Billion | India | Rs519.80 | +1.25% | +6.39% | 2.83 Million |
| 79 |
Healius Ltd
AU:HLS |
$249.19 Million | AU$352.19 Million | Australia | AU$0.49 | +0.00% | +24.36% | 89.96 Million |
| 80 |
INTERGRATED DIA.H DL 025
F:8I8 |
$247.39 Million | €211.60 Million | Germany | €0.36 | -7.14% | -8.08% | 23.20K |
| 81 |
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
$244.68 Million | CN¥1.67 Billion | China | CN¥41.73 | -4.25% | -5.05% | 13.88 Million |
| 82 |
Prodia Widyahusada Tbk PT
JK:PRDA |
$199.96 Million | Rp3.41 Trillion | Indonesia | Rp3640.00 | -2.15% | +4.00% | 36.61 Million |
| 83 |
Monash Ivf Group Ltd
AU:MVF |
$198.50 Million | AU$280.54 Million | Australia | AU$0.72 | -0.69% | +1.41% | 17.15 Million |
| 84 |
Spectral Med Inc
TO:EDT |
$194.52 Million | CA$268.90 Million | Canada | CA$0.93 | +5.68% | -14.68% | 1.16 Million |
| 85 |
Exagen Inc
NASDAQ:XGN |
$177.09 Million | $177.09 Million | USA | $8.70 | +3.57% | +10.41% | 8.46 Million |
| 86 |
Krsnaa Diagnostics Limited
NSE:KRSNAA |
$174.69 Million | Rs16.15 Billion | India | Rs497.95 | +0.30% | -3.31% | 1.27 Million |
| 87 |
Cancer Rop Co. Ltd.
KQ:180400 |
$125.94 Million | ₩185.83 Billion | Korea | ₩1888.00 | -0.37% | -7.90% | 1.14 Million |
| 88 |
Fonar Corporation
NASDAQ:FONR |
$117.84 Million | $117.84 Million | USA | $19.09 | +0.00% | +0.95% | 2.89 Million |
| 89 |
Scope Fluidics SA
WAR:SCP |
$111.48 Million | zł405.07 Million | Poland | zł148.60 | -3.63% | +11.56% | 88.43K |
| 90 |
MDxHealth SA ADR
NASDAQ:MDXH |
$111.46 Million | $111.46 Million | USA | $2.17 | -4.82% | -6.06% | 5.64 Million |
| 91 |
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX |
$104.06 Million | $104.06 Million | USA | $3.18 | +0.00% | +5.30% | 6.74 Million |
| 92 |
Green Cross Lab Cell Corporation
KQ:144510 |
$99.29 Million | ₩146.51 Billion | Korea | ₩9750.00 | -6.88% | -29.81% | 1.00 Million |
| 93 |
Burning Rock Biotech Ltd
NASDAQ:BNR |
$97.39 Million | $97.39 Million | USA | $11.05 | -9.87% | -18.21% | 706.66K |
| 94 |
SCOPE FLUIDICS SA ZY-10
F:S84 |
$94.51 Million | €80.84 Million | Germany | €28.80 | -3.84% | +10.77% | 0.00 |
| 95 |
Eurofins-Cerep SA
PA:ALECR |
$91.80 Million | €78.52 Million | France | €18400.00 | +0.00% | +0.00% | 6.00 |
| 96 |
OncoCyte Corp
NASDAQ:OCX |
$90.37 Million | $90.37 Million | USA | $3.16 | +0.00% | +0.00% | 1.44 Million |
| 97 |
Bionet
TWO:1784 |
$85.45 Million | NT$2.71 Billion | Taiwan | NT$52.20 | -2.97% | -4.57% | 1.62 Million |
| 98 |
Selvita S.A.
WAR:SLV |
$84.14 Million | zł305.74 Million | Poland | zł16.66 | -0.83% | -11.85% | 1.13 Million |
| 99 |
BioPorto
CO:BIOPOR |
$79.40 Million | Dkr507.47 Million | Denmark | Dkr1.03 | -0.49% | -0.97% | 6.26 Million |
| 100 |
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
$73.53 Million | R$374.71 Million | Brazil | R$2.46 | -5.75% | -16.61% | 2.06 Million |
| 101 |
DIVA Laboratories Ltd
TWO:4153 |
$57.11 Million | NT$1.81 Billion | Taiwan | NT$30.90 | +0.82% | +1.81% | 387.30K |
| 102 |
Pangaea Oncology S.A.
MC:PANG |
$51.36 Million | €43.93 Million | Spain | €1.47 | +0.00% | +2.80% | 31.36K |
| 103 |
Access Bio Inc
KQ:950130 |
$45.77 Million | ₩67.53 Billion | Korea | ₩1920.00 | -2.04% | -5.42% | 2.88 Million |
| 104 |
Optipharm.CO.LTD
KQ:153710 |
$43.20 Million | ₩63.74 Billion | Korea | ₩4345.00 | -0.69% | +0.00% | 233.30K |
| 105 |
Cryosite Ltd
AU:CTE |
$42.13 Million | AU$59.55 Million | Australia | AU$1.22 | +0.00% | -2.79% | 23.20K |
| 106 |
Cytogen Inc
KQ:217330 |
$36.66 Million | ₩54.10 Billion | Korea | ₩2345.00 | -5.25% | -12.17% | 1.44 Million |
| 107 |
P&K Skin Research Center Co. Ltd
KQ:347740 |
$35.52 Million | ₩52.42 Billion | Korea | ₩1815.00 | -0.11% | +10.00% | 955.97K |
| 108 |
Precipio Inc
NASDAQ:PRPO |
$31.34 Million | $31.34 Million | USA | $19.35 | +3.59% | -8.94% | 1.04 Million |
| 109 |
Gencurix Inc
KQ:229000 |
$31.07 Million | ₩45.85 Billion | Korea | ₩1957.00 | +0.88% | +4.88% | 6.24 Million |
| 110 |
INIFY LABORATORIES AB
F:WY60 |
$30.74 Million | €26.29 Million | Germany | €0.41 | -6.79% | +7.85% | 0.00 |
| 111 |
Biocartis Group NV
BR:BCART |
$27.24 Million | €23.30 Million | Belgium | €0.29 | +0.00% | +0.00% | 0.00 |
| 112 |
Genoray Co. Ltd
KQ:122310 |
$25.44 Million | ₩37.54 Billion | Korea | ₩3090.00 | -0.80% | -2.83% | 150.28K |
| 113 |
NanoRepro AG
XETRA:NN6 |
$22.45 Million | €19.20 Million | Germany | €1.64 | +3.81% | -4.39% | 171.61K |
| 114 |
Bcal Diagnostics Ltd
AU:BDX |
$20.87 Million | AU$29.49 Million | Australia | AU$0.08 | +0.00% | +2.56% | 3.31 Million |
| 115 |
Quantum Cyber N.V.
NASDAQ:QUCY |
$20.72 Million | $20.72 Million | USA | $0.91 | -5.21% | -10.78% | 11.44 Million |
| 116 |
Diagnos Laboratorium Utama PT Tbk
JK:DGNS |
$20.51 Million | Rp350.00 Billion | Indonesia | Rp280.00 | -0.71% | +6.87% | 64.58 Million |
| 117 |
GeneMatrix Inc
KQ:109820 |
$19.20 Million | ₩28.33 Billion | Korea | ₩1419.00 | -0.91% | -5.71% | 5.83 Million |
| 118 |
Enzo Biochem Inc
NYSE:ENZ |
$16.44 Million | $16.44 Million | USA | $0.54 | +0.00% | +0.00% | 1.75K |
| 119 |
SenzaGen AB
ST:SENZA |
$15.21 Million | Skr141.32 Million | Sweden | Skr4.79 | +7.64% | +7.64% | 633.68K |
| 120 |
Microba Life Sciences Ltd
AU:MAP |
$15.08 Million | AU$21.31 Million | Australia | AU$0.04 | +0.00% | -12.50% | 7.19 Million |
| 121 |
RHYTHM Biosciences Ltd
AU:RHY |
$14.62 Million | AU$20.66 Million | Australia | AU$0.06 | -3.08% | -5.97% | 4.78 Million |
| 122 |
bioAffinity Technologies, Inc.
NASDAQ:BIAF |
$13.63 Million | $13.63 Million | USA | $3.03 | -3.50% | -15.13% | 40.15 Million |
| 123 |
Inoviq Ltd
AU:IIQ |
$13.45 Million | AU$19.00 Million | Australia | AU$0.14 | -1.82% | +3.85% | 2.37 Million |
| 124 |
AroCell AB
ST:AROC |
$13.39 Million | Skr124.39 Million | Sweden | Skr0.54 | +0.00% | +0.00% | 724.84K |
| 125 |
Genetic Signatures Ltd
AU:GSS |
$12.70 Million | AU$17.94 Million | Australia | AU$0.08 | +0.00% | -5.95% | 13.74 Million |
| 126 |
NSN Co. Ltd
KQ:031860 |
$12.68 Million | ₩18.71 Billion | Korea | ₩693.00 | +17.26% | +15.69% | 50.75 Million |
| 127 |
INOVIQ LTD.
F:EGQ0 |
$12.67 Million | €10.84 Million | Germany | €0.08 | -1.91% | +4.76% | 0.00 |
| 128 |
Malaysian Genomics Resource
KLSE:0155 |
$12.13 Million | RM48.30 Million | Malaysia | RM0.32 | -4.48% | -4.48% | 1.24 Million |
| 129 |
Biomaxima
WAR:BMX |
$10.96 Million | zł39.83 Million | Poland | zł9.50 | -2.06% | -4.04% | 43.41K |
| 130 |
Mainz Biomed BV
NASDAQ:MYNZ |
$9.49 Million | $9.49 Million | USA | $0.76 | -10.15% | -16.66% | 18.17 Million |
| 131 |
Check Cap Ltd
NASDAQ:CHEK |
$9.42 Million | $9.42 Million | USA | $139.00 | +0.72% | -2.80% | 22.52 Million |
| 132 |
Check-Cap Ltd
F:7CC |
$9.20 Million | €7.87 Million | Germany | €1.73 | +29.10% | -11.28% | 504.00 |
| 133 |
ENDRA Life Sciences Inc
NASDAQ:NDRA |
$7.32 Million | $7.32 Million | USA | $4.88 | +2.95% | +4.27% | 389.16K |
| 134 |
IZOTROPIC CORP.
F:1R3 |
$6.39 Million | €5.47 Million | Germany | €0.08 | +0.00% | -9.88% | 0.00 |
| 135 |
XWELL Inc.
NASDAQ:XWEL |
$5.47 Million | $5.47 Million | USA | $0.69 | -7.96% | -1.50% | 1.34 Million |
| 136 |
GENINCODE PLC LS -01
F:9PL |
$5.28 Million | €4.52 Million | Germany | €0.01 | -7.69% | +0.00% | 0.00 |
| 137 |
Avricore Health Inc
V:AVCR |
$4.57 Million | CA$6.32 Million | Canada | CA$0.05 | +11.11% | -16.67% | 1.66 Million |
| 138 |
Leveljump Healthcare Corp
V:JUMP |
$4.41 Million | CA$6.10 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 139 |
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB |
$4.36 Million | $4.36 Million | USA | $2.64 | -11.41% | -29.79% | 837.88K |
| 140 |
Genetic Technologies Ltd
AU:GTG |
$4.01 Million | AU$5.67 Million | Australia | AU$0.04 | +0.00% | +0.00% | 0.00 |
| 141 |
Applied DNA Sciences Inc
NASDAQ:APDN |
$3.99 Million | $3.99 Million | USA | $3.09 | +3.00% | +24.10% | 1.14 Million |
| 142 |
Euroespes S.A.
MC:EEP |
$3.95 Million | €3.38 Million | Spain | €0.34 | +0.00% | +0.00% | 0.00 |
| 143 |
Predilife
PA:ALPRE |
$3.89 Million | €3.33 Million | France | €0.85 | -7.61% | +0.00% | 16.94K |
| 144 |
Genetic Technologies Ltd
NASDAQ:GENE |
$3.71 Million | $3.71 Million | USA | $1965.70 | +0.40% | -2.11% | 18.23K |
| 145 |
Telo Genomics Corp
V:TELO |
$3.63 Million | CA$5.02 Million | Canada | CA$0.05 | +0.00% | -28.57% | 2.73 Million |
| 146 |
StageZero Life Sciences Ltd
TO:SZLS |
$3.58 Million | CA$4.94 Million | Canada | CA$0.04 | +0.00% | +0.00% | 0.00 |
| 147 |
Centogene N.V.
NASDAQ:CNTGF |
$3.48 Million | $3.48 Million | USA | $0.12 | +0.00% | +0.00% | 126.40K |
| 148 |
Immunovia publ AB
ST:IMMNOV |
$3.19 Million | Skr29.60 Million | Sweden | Skr0.04 | -36.78% | -42.86% | 197.22 Million |
| 149 |
GENETIC ANALYSIS NK -60
F:8V8 |
$2.36 Million | €2.02 Million | Germany | €0.03 | +0.61% | -3.49% | 0.00 |
| 150 |
iSpecimen Inc
NASDAQ:ISPC |
$2.00 Million | $2.00 Million | USA | $0.79 | -9.35% | -11.28% | 4.53 Million |
How Diagnostics & Research Companies Are Ranked by Market Cap
Diagnostics & Research companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries